Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - BOOK
LB  - 1.
AU  - Kirk, J
AU  - Butler, G
AU  - on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED)
TI  - Treatment of children with recombinant human growth hormone (r-hGH)
PB  - Shared Care Guidelines
PY  - 2006
ER  - 
TY  - JOUR
LB  - 2.
AU  - Rosenfeld, RG
TI  - Editorial: Is growth hormone deficiency a viable diagnosis?
J2  - J Clin Endocrinol Metab
PY  - 1997
VL  - 82
SP  - 349
EP  - 351
ER  - 
TY  - JOUR
LB  - 3.
AU  - Juul, A
AU  - Bernasconi, S
AU  - Clayton, PE
AU  - Kiess, W
AU  - DeMuink-Keizer Schrama, S
AU  - and Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)
TI  - European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency
J2  - Horm Res
PY  - 2002
VL  - 58
SP  - 233
EP  - 241
ER  - 
TY  - GEN
LB  - 4.
AU  - Warner, J
AU  - and British Society for Paediatric Endocrinology and Diabetes
TI  - Submission of Evidence for the National Institute of Clinical Excellence Health Technology Appraisal: The Use of Human Growth Hormone in Children (review)
PY  - 2008
ER  - 
TY  - JOUR
LB  - 5.
AU  - Growth Hormone Research Society
TI  - Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society
J2  - J Clin Endocrinol Metab
PY  - 2000
VL  - 85
SP  - 3990
EP  - 3993
ER  - 
TY  - JOUR
LB  - 6.
AU  - Bryant, J
AU  - Cave, C
AU  - Mihaylova, B
AU  - Chase, D
AU  - McIntyre, L
AU  - Gerard, K
TI  - Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation
J2  - Health Technol Assess
PY  - 2002
VL  - 6
IS  - 18
ER  - 
TY  - ELEC
LB  - 7.
AU  - UK Child Growth Foundation
TI  - Growth hormone deficiency
UR  - www.childgrowthfoundation.org/ghd.htm
M1  - 12 May 2008
ER  - 
TY  - JOUR
LB  - 8.
AU  - Thomas, M
AU  - Massa, G
AU  - Craen, M
AU  - de Zegher, F
AU  - Bourguignon, JP
AU  - Heinrichs, C
TI  - Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986–2001
J2  - Eur J Endocrinol
PY  - 2004
VL  - 151
SP  - 67
EP  - 72
ER  - 
TY  - JOUR
LB  - 9.
AU  - Stochholm, K
AU  - Gravholt, CH
AU  - Laursen, T
AU  - Jorgensen, JO
AU  - Laurberg, P
AU  - Andersen, M
TI  - Incidence of GH deficiency: a nationwide study
J2  - Eur J Endocrinol
PY  - 2006
VL  - 155
SP  - 61
EP  - 71
ER  - 
TY  - JOUR
LB  - 10.
AU  - Turner, H
TI  - A syndrome of infantilism, congenital webbed neck, and cubitus valgus
J2  - Endocrinology
PY  - 1938
VL  - 23
SP  - 566
EP  - 574
ER  - 
TY  - JOUR
LB  - 11.
AU  - Bondy, CA
TI  - Clinical practice guideline: care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group
J2  - J Clin Endocrinol Metab
PY  - 2007
VL  - 92
SP  - 10
EP  - 25
ER  - 
TY  - JOUR
LB  - 12.
AU  - Quigley, CA
AU  - Crowe, BJ
AU  - Anglin, DG
AU  - Chipman, JJ
TI  - Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height
J2  - J Clin Endocrinol Metab
PY  - 2002
VL  - 87
SP  - 2033
EP  - 2041
ER  - 
TY  - JOUR
LB  - 13.
AU  - Rao, E
AU  - Weiss, B
AU  - Fukami, M
AU  - Rump, A
AU  - Niesler, B
AU  - Mertz, A
TI  - Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
J2  - Nat Genet
PY  - 1997
VL  - 16
SP  - 54
EP  - 63
ER  - 
TY  - JOUR
LB  - 14.
AU  - Gravholt, CH
TI  - Epidemiological, endocrine and metabolic features in Turner syndrome
J2  - Eur J Endocrinol
PY  - 2004
VL  - 151
SP  - 657
EP  - 687
ER  - 
TY  - ELEC
LB  - 15.
AU  - WHO Collaborating Centre for the Epidemiological Surveillance of Congenital Anomalies
UR  - www.eurocat.ulster.ac.uk/pdf/EUROCAT-Annual-Report-2005-for-WHO.pdf
M1  - 22 April 2009
ER  - 
TY  - JOUR
LB  - 16.
AU  - Massa, G
AU  - Verlinde, F
AU  - De, SJ
AU  - Thomas, M
AU  - Bourguignon, JP
AU  - Craen, M
TI  - Trends in age at diagnosis of Turner syndrome
J2  - Arch Dis Child
PY  - 2005
VL  - 90
SP  - 267
EP  - 268
ER  - 
TY  - JOUR
LB  - 17.
AU  - Stochholm, K
AU  - Juul, S
AU  - Juel, K
AU  - Naeraa, RW
AU  - Gravholt, CH
TI  - Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome
J2  - J Clin Endocrinol Metab
PY  - 2006
VL  - 91
SP  - 3897
EP  - 3902
ER  - 
TY  - JOUR
LB  - 18.
AU  - Paterson, WF
AU  - Donaldson, MD
TI  - Growth hormone therapy in the Prader–Willi syndrome
J2  - Arch Dis Child
PY  - 2003
VL  - 88
SP  - 283
EP  - 285
ER  - 
TY  - JOUR
LB  - 19.
AU  - Cassidy, SB
TI  - Prader–Willi syndrome. Characteristics, management, and etiology
J2  - Alabama J Med Sci
PY  - 1987
VL  - 24
SP  - 169
EP  - 175
ER  - 
TY  - JOUR
LB  - 20.
AU  - Chen, C
AU  - Visootsak, J
AU  - Dills, S
AU  - Graham, JM
TI  - Prader–Willi syndrome: an update and review for the primary pediatrician
J2  - Clin Pediatr
PY  - 2007
VL  - 46
SP  - 580
EP  - 591
ER  - 
TY  - JOUR
LB  - 21.
AU  - Butler, M
TI  - Prader–Willi syndrome: current understanding of cause and diagnosis
J2  - Am J Med Genet
PY  - 1990
VL  - 35
SP  - 319
EP  - 332
ER  - 
TY  - JOUR
LB  - 22.
AU  - Carrel, AL
AU  - Moerchen, V
AU  - Myers, SE
AU  - Bekx, MT
AU  - Whitman, BY
AU  - Allen, DB
TI  - Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome
J2  - J Pediatr
PY  - 2004
VL  - 145
SP  - 744
EP  - 749
ER  - 
TY  - JOUR
LB  - 23.
AU  - Whittington, JE
AU  - Holland, AJ
AU  - Webb, T
AU  - Butler, J
AU  - Clarke, D
AU  - Boer, H
TI  - Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region
J2  - J Med Genet
PY  - 2001
VL  - 38
SP  - 792
EP  - 798
ER  - 
TY  - JOUR
LB  - 24.
AU  - Sarborio, P
AU  - Hahn, S
AU  - Hisano, S
AU  - Latta, K
AU  - Scheinman, J
AU  - Chan, J
TI  - Chronic renal failure: and overview from a pediatric perspective
J2  - Nephron
PY  - 1998
VL  - 80
SP  - 134
EP  - 148
ER  - 
TY  - JOUR
LB  - 25.
AU  - Tönshoff, B
AU  - Mehls, O
TI  - Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment
J2  - J Nephrol
PY  - 1995
VL  - 8
SP  - 133
EP  - 142
ER  - 
TY  - JOUR
LB  - 26.
AU  - Schaefer, F
AU  - Wingen, AM
AU  - Hennicke, M
AU  - Rigden, S
AU  - Mehls, O
TI  - Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood
J2  - Pediatr Nephrol
PY  - 1996
VL  - 10
SP  - 288
EP  - 293
ER  - 
TY  - JOUR
LB  - 27.
AU  - Mahan, JD
AU  - Warady, BA
AU  - Fielder, P
AU  - Gipson, DS
AU  - Greenbaum, L
AU  - Juarez-Congelosi, MD
TI  - Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement
J2  - Pediatr Nephrol
PY  - 2006
VL  - 21
SP  - 917
EP  - 930
ER  - 
TY  - ELEC
LB  - 28.
AU  - National Kidney Foundation Kidney Disease Outcomes Quality Initiative
TI  - K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease
UR  - www.kidney.org/PROFESSIONALS/kdoqi/guidelines_ckd/toc.htm
M1  - 23 February 2009
ER  - 
TY  - JOUR
LB  - 29.
AU  - Kari, J
AU  - Gonzalez, C
AU  - Ledermann, S
AU  - Shaw, V
AU  - Rees, L
TI  - Outcome and growth of infants with severe chronic renal failure
J2  - Kidney Int
PY  - 2000
VL  - 57
SP  - 1681
EP  - 1687
ER  - 
TY  - JOUR
LB  - 30.
AU  - Parekh, R
AU  - Flynn, J
AU  - Smoyer, W
AU  - Milne, J
AU  - Kershaw, D
AU  - Bunchman, T
TI  - Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy
J2  - J Am Soc Nephrol
PY  - 2001
VL  - 12
SP  - 2418
EP  - 2426
ER  - 
TY  - JOUR
LB  - 31.
AU  - Wingen, AM
AU  - Mehls, O
TI  - Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid?
J2  - Pediatr Nephrol
PY  - 2002
VL  - 17
SP  - 111
EP  - 120
ER  - 
TY  - ELEC
LB  - 32.
AU  - National Kidney Foundation Kidney Disease Outcomes Quality Initiative
TI  - Clinical practice guidelines for nutrition in chronic renal failure
UR  - www.kidney.org/PROFESSIONALS/kdoqi/guidelines_updates/doqi_nut.html
M1  - 23 February 2009
ER  - 
TY  - JOUR
LB  - 33.
AU  - Furth, SL
TI  - Growth and nutrition in children with chronic kidney disease
J2  - Adv Chronic Kidney Dis
PY  - 2005
VL  - 12
SP  - 366
EP  - 371
ER  - 
TY  - CHAP
LB  - 34.
AU  - Lewis, M
AU  - Shaw, J
AU  - Reid, C
AU  - Evans, J
AU  - Webb, N
AU  - Verrier-Jones, K
TI  - Growth in children with established renal failure: a registry analysis
A2  - Ansell, D
A2  - Feest, T
A2  - Tomson, C
A2  - Williams, A
A2  - Warwick, G
CY  - UK Renal Registry Report 2006 Bristol, UK
PB  - UK Renal Registry
PY  - 2006
SP  - 243
EP  - 248
ER  - 
TY  - JOUR
LB  - 35.
AU  - Groothof, J
AU  - Offringa, M
AU  - Van Eck-Smit, B
AU  - Gruppen, M
AU  - Van der Kar, N
AU  - Wolff, ED
TI  - Severe bone disease and low bone mineral density after juvenile renal failure
J2  - Kidney Int
PY  - 2003
VL  - 63
SP  - 266
EP  - 275
ER  - 
TY  - JOUR
LB  - 36.
AU  - Rizzoni, G
AU  - Broyer, M
AU  - Brunner, F
AU  - Brynger, H
AU  - Challah, S
AU  - Kramer, P
TI  - Combined report on regular dialysis and transplantation of children in Europe, XIII, 1983
J2  - Proc Eur Dial Trans Assoc
PY  - 1985
VL  - 21
SP  - 95
ER  - 
TY  - RPRT
LB  - 37.
AU  - Lewis, M
AU  - Shaw, J
AU  - Reid, C
AU  - Evans, J
AU  - Webb, N
AU  - Verrier-Jones, K
TI  - Demography and management of childhood established renal failure in the UK
AU  - Ansell, BM
AU  - Feest, T
AU  - Tomson, C
AU  - Williams, A
A2  - Warwick, G
TI  - UK Renal Registry Report 2006
CY  - Bristol, UK
PB  - UK Renal Registry
PY  - 2006
SP  - 227
EP  - 241
ER  - 
TY  - GEN
LB  - 38.
AU  - Royal College of Obstetricians and Gynaecologists
TI  - The investigation and management of the small-for-gestational-age fetus
CY  - London
PB  - RCOG
PY  - 2002
ER  - 
TY  - JOUR
LB  - 39.
AU  - Lee, PA
AU  - Chernausek, SD
AU  - Hokken-Koelega, ACS
AU  - Czernichow, P
TI  - International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001
J2  - Pediatrics
PY  - 2003
VL  - 111
SP  - 1253
EP  - 1261
ER  - 
TY  - JOUR
LB  - 40.
AU  - Karlberg, J
AU  - Albertsson-Wikland, K
AU  - Kwan, EY
AU  - Lam, B
AU  - Low, LC
TI  - The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age
J2  - Horm Res
PY  - 1997
VL  - 48
IS  - Suppl.1
SP  - 17
EP  - 24
ER  - 
TY  - JOUR
LB  - 41.
AU  - Ong, K
AU  - Ahmed, M
AU  - Emmett, P
AU  - Preece, M
AU  - Dunger, DB
AU  - for the Avon Longitudinal Study of Pregnancy and Childhood Study Team
TI  - Association between post-natal catch-up growth and obesity in childhood: prospective cohort study
J2  - BMJ
PY  - 2000
VL  - 320
SP  - 967
EP  - 971
ER  - 
TY  - JOUR
LB  - 42.
AU  - Albertsson-Wikland, K
AU  - Karlberg, J
TI  - Postnatal growth of children born small for gestational age
J2  - Acta Paediatr
PY  - 1997
SP  - 193
EP  - 195
ER  - 
TY  - JOUR
LB  - 43.
AU  - Huiming, Y
AU  - Meng, M
AU  - Chaomin, W
AU  - Fan, Y
TI  - Growth Hormone Treatment for short stature in children with intrauterine growth retardation (protocol)
J2  - Cochrane Database Syst Rev
PY  - 2006
IS  - 4
ER  - 
TY  - JOUR
LB  - 44.
AU  - Karlberg, J
AU  - Albertsson-Wikland, K
TI  - Growth in full term small-for-gestational-age infants: from birth to final height
J2  - Pediatr Res
PY  - 1995
VL  - 38
SP  - 733
EP  - 739
ER  - 
TY  - JOUR
LB  - 45.
AU  - Tuvemo, T
AU  - Cnattingius, S
AU  - Jonsson, B
TI  - Prediction of male adult stature using anthropometric data at birth: a nationwide population-based study
J2  - Pediatr Res
PY  - 1999
VL  - 46
SP  - 491
EP  - 495
ER  - 
TY  - JOUR
LB  - 46.
AU  - Albertsson-Wikland, K
AU  - Karlberg, J
TI  - Natural growth in children born small for gestational age with and without catch-up growth
J2  - Acta Paediatr
PY  - 1994
VL  - 399
IS  - Suppl.
SP  - 64
EP  - 70
ER  - 
TY  - JOUR
LB  - 47.
AU  - Karlberg, J
AU  - Albertsson-Wikland, K
TI  - Growth in full term small-for-gestational-age infants: from birth to final height
J2  - Pediatr Res
PY  - 1995
VL  - 38
SP  - 733
EP  - 739
ER  - 
TY  - JOUR
LB  - 48.
AU  - Hokken-Koelega, A
AU  - De Ridder, M
AU  - Lemmen, R
AU  - Den Hartog, H
AU  - De Muinck Keizer-Schrama, S
AU  - Drop, S
TI  - Children born small for gestational age: do they catch up?
J2  - Pediatr Res
PY  - 1995
VL  - 38
SP  - 267
EP  - 271
ER  - 
TY  - JOUR
LB  - 49.
AU  - Blum, WF
AU  - Crowe, BJ
AU  - Quigley, CA
AU  - Jung, H
AU  - Cau, D
AU  - Ross, JL
TI  - Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two year results of a randomized, controlled, multicenter trial
J2  - J Clin Endocrinol Metab
PY  - 2007
VL  - 92
SP  - 219
EP  - 228
ER  - 
TY  - GEN
LB  - 50.
AU  - Eli Lilly
TI  - Lilly and humatrope: a lasting commitment
CY  - Indianapolis, IN
PB  - Eli Lilly and Co. Ltd
PY  - 2006
ER  - 
TY  - JOUR
LB  - 51.
AU  - Langer, L
TI  - Mesomelic dwarfism of the hypoplastic ulna, fibula, mandible type
J2  - Radiology
PY  - 1967
VL  - 89
SP  - 660
ER  - 
TY  - JOUR
LB  - 52.
AU  - Zinn, AR
AU  - Wei, F
AU  - Zhang, L
AU  - Elder, FF
AU  - Scott, CI, Jr
AU  - Marttila, P
TI  - Complete SHOX deficiency causes Langer mesomelic dysplasia
J2  - Am J Med Genet
PY  - 2002
VL  - 110
SP  - 158
EP  - 163
ER  - 
TY  - JOUR
LB  - 53.
AU  - Binder, G
AU  - Schwarze, CP
AU  - Ranke, MB
TI  - Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone
J2  - J Clin Endocrinol Metab
PY  - 2000
VL  - 85
SP  - 245
EP  - 249
ER  - 
TY  - JOUR
LB  - 54.
AU  - Ezquieta, B
AU  - Cueva, E
AU  - Oliver, A
AU  - Gracia, R
TI  - SHOX intragenic microsatellite analysis in patients with short stature
J2  - J Pediatr Endocrinol Metab
PY  - 2002
VL  - 15
SP  - 139
EP  - 148
ER  - 
TY  - JOUR
LB  - 55.
AU  - Ogata, T
AU  - Muroya, K
AU  - Sasaki, G
AU  - Nishimura, G
AU  - Kitoh, H
AU  - Hattori, T
TI  - SHOX nullizygosity and haploinsufficiency in a Japanese family: implication for the development of Turner skeletal features
J2  - J Clin Endocrinol Metab
PY  - 2002
VL  - 87
SP  - 1390
EP  - 1394
ER  - 
TY  - JOUR
LB  - 56.
AU  - Rappold, GA
AU  - Fukami, M
AU  - Niesler, B
AU  - Schiller, S
AU  - Zumkeller, W
AU  - Bettendorf, M
TI  - Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature
J2  - J Clin Endocrinol Metab
PY  - 2002
VL  - 87
SP  - 1402
EP  - 1406
ER  - 
TY  - JOUR
LB  - 57.
AU  - Binder, G
AU  - Ranke, MB
AU  - Martin, DD
TI  - Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature
J2  - J Clin Endocrinol Metab
PY  - 2003
VL  - 88
SP  - 4891
EP  - 4896
ER  - 
TY  - JOUR
LB  - 58.
AU  - Stuppia, L
AU  - Calabrese, G
AU  - Gatta, V
AU  - Pintor, S
AU  - Morizio, E
AU  - Fantasia, D
TI  - SHOX mutations detected by FISH and direct sequencing in patients with short stature
J2  - J Med Genet
PY  - 2003
VL  - 40
SP  - E11
ER  - 
TY  - JOUR
LB  - 59.
AU  - Huber, C
AU  - Rosilio, M
AU  - Munnich, A
AU  - Cormier-Daire, V
TI  - High incidence of SHOX anomalies in individuals with short stature
J2  - J Med Genet
PY  - 2006
VL  - 43
SP  - 735
EP  - 739
ER  - 
TY  - JOUR
LB  - 60.
AU  - Binder, G
AU  - Renz, A
AU  - Martinez, A
AU  - Keselman, A
AU  - Hesse, V
AU  - Riedl, SW
TI  - SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: Prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity
J2  - J Clin Endocrinol Metab
PY  - 2004
VL  - 89
SP  - 4403
EP  - 4408
ER  - 
TY  - JOUR
LB  - 61.
AU  - Allen, DB
TI  - Growth hormone therapy for short stature: is the benefit worth the burden?
J2  - Pediatrics
PY  - 2006
VL  - 118
SP  - 343
EP  - 348
ER  - 
TY  - JOUR
LB  - 62.
AU  - Munns, C
AU  - Glass, I
AU  - Flanagan, S
AU  - Hayes, M
AU  - Williams, B
AU  - Berry, M
TI  - Familial growth and skeletal features associated with SHOX haploinsufficiency
J2  - J Pediatr Endocrinol Metab
PY  - 2003
VL  - 16
SP  - 987
EP  - 996
ER  - 
TY  - JOUR
LB  - 63.
AU  - Voss, LD
AU  - Mulligan, J
TI  - Bullying at school: are short pupils at risk? Questionnaire study in a cohort
J2  - BMJ
PY  - 2000
VL  - 320
SP  - 612
EP  - 613
ER  - 
TY  - JOUR
LB  - 64.
AU  - Tanaka, T
AU  - Cohen, P
AU  - Clayton, PE
AU  - Laron, Z
AU  - Hintz, RL
AU  - Sizonenko, PC
TI  - Diagnosis and management of growth hormone deficiency in childhood and adolescence: Part 2: Growth hormone treatment in growth hormone deficient children
J2  - Growth Horm IGF Res
PY  - 2002
VL  - 12
SP  - 323
EP  - 341
ER  - 
TY  - JOUR
LB  - 65.
AU  - Rosén, T
AU  - Wilhelmsen, L
AU  - Bengtsson, BA
TI  - Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency
J2  - Clin Endocrinol
PY  - 1998
VL  - 48
SP  - 525
EP  - 526
ER  - 
TY  - JOUR
LB  - 66.
AU  - Elsheikh, M
AU  - Dunger, DB
AU  - Conway, GS
AU  - Wass, JAH
TI  - Turner’s Syndrome in adulthood
J2  - Endocrine Reviews
PY  - 2002
VL  - 23
SP  - 120
EP  - 140
ER  - 
TY  - JOUR
LB  - 67.
AU  - Höybe, C
AU  - Hilding, A
AU  - Jacobsson, H
AU  - Thorén, M
TI  - Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity
J2  - J Clin Endocrinol Metab
PY  - 2002
VL  - 87
SP  - 3590
EP  - 3597
ER  - 
TY  - JOUR
LB  - 68.
AU  - Reinehr, T
AU  - Kleber, M
AU  - Toschke, A
TI  - Small for gestational age (SGA) status is associated with metabolic syndrome in overweight children
J2  - Eur J Endocrinol
PY  - 2009
VL  - 160
SP  - 579
EP  - 584
ER  - 
TY  - BOOK
LB  - 69.
AU  - Barker, D
TI  - Mothers, babies, and disease in later life
CY  - London
PB  - British Medical Journal Publishing Group
PY  - 1998
ER  - 
TY  - GEN
LB  - 70.
AU  - National Institute for Health and Clinical Excellence National Collaborating Centre for Primary Care
TI  - Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children
PY  - 2006
ER  - 
TY  - JOUR
LB  - 71.
AU  - Rajaram, S
AU  - Baylink, D
AU  - Mohan, S
TI  - Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions
J2  - Endocrine Reviews
PY  - 1997
VL  - 18
SP  - 801
EP  - 831
ER  - 
TY  - JOUR
LB  - 72.
AU  - Cohen, P
AU  - Peehl, D
AU  - Lamson, G
AU  - Rosenfeld, R
TI  - Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
J2  - J Clin Endocrinol Metab
PY  - 1991
VL  - 73
SP  - 401
EP  - 407
ER  - 
TY  - JOUR
LB  - 73.
AU  - Lippman, M
TI  - The development of biological therapies for breast cancer
J2  - Science
PY  - 1993
VL  - 259
SP  - 631
EP  - 632
ER  - 
TY  - JOUR
LB  - 74.
AU  - Ezquieta, B
AU  - Cueva, E
AU  - Oliver, A
AU  - Gracia, R
TI  - SHOX intragenic microsatellite analysis in patients with short stature
J2  - J Pediatr Endocrinol Metab
PY  - 2002
VL  - 15
SP  - 139
EP  - 148
ER  - 
TY  - GEN
LB  - 75.
AU  - National Institute of Health and Clinical Evidence
TI  - Guidance on the use of human growth hormone (somatropin) in children with growth failure
PY  - 2002
ER  - 
TY  - ELEC
LB  - 76.
AU  - National Kidney Foundation
TI  - KDOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease
UR  - www.kidney.org/professionals/KDOQI/guidelines_pedbone/guide11.htm
M1  - 23 February 2009
ER  - 
TY  - JOUR
LB  - 77.
AU  - Clayton, PE
AU  - Cianfarani, S
AU  - Czernichow, P
AU  - Johannsson, G
AU  - Rapaport, R
AU  - Rogol, A
TI  - Consensus statement: management of the child born small for gestational age through to adulthood: A consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society
J2  - J Clin Endocrinol Metab
PY  - 2007
VL  - 92
SP  - 804
EP  - 810
ER  - 
TY  - ELEC
LB  - 78.
AU  - Pfizer
TI  - Genotropin full prescribing information
UR  - www.accessdata.fda.gov/drugsatfda_docs/label/2008/020280s060lbl.pdf
M1  - 29 July 2009
ER  - 
TY  - ELEC
LB  - 79.
AU  - Eli Lilly
TI  - Humatrope 6mg, 12mg, or 24mg powder and solvent for solution for injection
UR  - http://emc.medicines.org.uk/medicine/601/SPC/Humatrope%206mg,%2012mg,%20or%2024mg%20powder%20and%20solvent%20for%20solution%20for%20injection
M1  - 2 June 2009
ER  - 
TY  - ELEC
LB  - 80.
AU  - Sandoz
TI  - Omnitrope Summary of Product Characteristics
UR  - www.emea.europa.eu/humandocs/PDFs/EPAR/Omnitrope/H-607-PI-en.pdf
M1  - 2 June 2009
ER  - 
TY  - ELEC
LB  - 81.
AU  - Eli Lilly and Company Ltd
TI  - Humatrope 6mg, 12mg, or 24mg powder and solvent for solution for injection
UR  - http://emc.medicines.org.uk
M1  - 23 December 2008
ER  - 
TY  - JOUR
LB  - 82.
AU  - Grunfeld, C
AU  - Thompson, M
AU  - Brown, SJ
AU  - Richmond, G
AU  - Lee, D
AU  - Muurahainen, N
TI  - Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12-week induction and 24-week maintenance therapy
J2  - JAIDS
PY  - 2007
VL  - 45
SP  - 286
EP  - 297
ER  - 
TY  - GEN
LB  - 83.
AU  - NHS Centre for Reviews and Dissemination
TI  - Undertaking systematic reviews of research on effectiveness
ET  - 2nd
CY  - York
PB  - University of York
PY  - 2001
ER  - 
TY  - JOUR
LB  - 84.
AU  - Soliman, AT
AU  - Abdul Khadir, MM
TI  - Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study
J2  - J Trop Pediatr
PY  - 1996
VL  - 42
SP  - 281
EP  - 286
ER  - 
TY  - JOUR
LB  - 85.
AU  - Davenport, ML
AU  - Crowe, BJ
AU  - Travers, SH
AU  - Rubin, K
AU  - Ross, JL
AU  - Fechner, PY
TI  - Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial
J2  - J Clin Endocrinol Metab
PY  - 2007
VL  - 92
SP  - 3406
EP  - 3416
ER  - 
TY  - JOUR
LB  - 86.
AU  - Stephure, DK
AU  - Canadian Growth Hormone Advisory Committee
TI  - Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial
J2  - J Clin Endocrinol Metab
PY  - 2005
VL  - 90
SP  - 3360
EP  - 3366
ER  - 
TY  - JOUR
LB  - 87.
AU  - Rovet, J
AU  - Holland, J
TI  - Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group
J2  - Horm Res
PY  - 1993
VL  - 39
IS  - Suppl. 2
SP  - 60
EP  - 64
ER  - 
TY  - JOUR
LB  - 88.
AU  - Gravholt, CH
AU  - Naeraa, RW
AU  - Brixen, K
AU  - Kastrup, KW
AU  - Mosekilde, L
AU  - Jorgensen, JO
TI  - Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study
J2  - Pediatrics
PY  - 2002
VL  - 110
SP  - 889
EP  - 896
ER  - 
TY  - JOUR
LB  - 89.
AU  - Gravholt, CH
AU  - Hjerrild, BE
AU  - Naeraa, RW
AU  - Engbaek, F
AU  - Mosekilde, L
AU  - Christiansen, JS
TI  - Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome
J2  - Clin Endocrinol
PY  - 2005
VL  - 62
SP  - 616
EP  - 622
ER  - 
TY  - JOUR
LB  - 90.
AU  - Johnston, DI
AU  - Betts, P
AU  - Dunger, D
AU  - Barnes, N
AU  - Swift, PG
AU  - Buckler, JM
TI  - A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis
J2  - Arch Dis Child
PY  - 2001
VL  - 84
SP  - 76
EP  - 81
ER  - 
TY  - JOUR
LB  - 91.
AU  - Festen, DA
AU  - van, TA
AU  - Duivenvoorden, HJ
AU  - Hokken-Koelega, AC
TI  - Adiponectin levels in prepubertal children with Prader–Willi syndrome before and during growth hormone therapy
J2  - J Clin Endocrinol Metab
PY  - 2007
VL  - 92
SP  - 1549
EP  - 1554
ER  - 
TY  - JOUR
LB  - 92.
AU  - Festen, DAM
AU  - Wevers, M
AU  - Lindgren, AC
AU  - Bohm, B
AU  - Otten, BJ
AU  - Wit, JM
TI  - Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader–Willi syndrome
J2  - Clin Endocrinol
PY  - 2008
VL  - 68
SP  - 919
EP  - 925
ER  - 
TY  - JOUR
LB  - 93.
AU  - de Lind van Wijngaarden Roderick, FA
AU  - de Klerk, L
AU  - Festen, D
AU  - Duivenvoorden, HJ
AU  - Otten, B
AU  - Hokken-Koelega, ACS
TI  - Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome
J2  - J Clin Endocrinol Metab
PY  - 2009
VL  - 94
SP  - 1274
EP  - 1280
ER  - 
TY  - JOUR
LB  - 94.
AU  - Festen, DAM
AU  - de Lind van Wijngaarden, R
AU  - van Eekelen, M
AU  - Otten, BJ
AU  - Wit, JM
AU  - Duivenvoorden, HJ
TI  - Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader–Willi syndrome
J2  - Clin Endocrinol
PY  - 2008
VL  - 69
SP  - 443
EP  - 451
ER  - 
TY  - JOUR
LB  - 95.
AU  - Carrel, AL
AU  - Myers, SE
AU  - Whitman, BY
AU  - Allen, DB
TI  - Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader–Willi syndrome: a controlled study
J2  - J Pediatr
PY  - 1999
VL  - 134
SP  - 215
EP  - 221
ER  - 
TY  - JOUR
LB  - 96.
AU  - Myers, SE
AU  - Carrel, AL
AU  - Whitman, BY
AU  - Allen, DB
TI  - Physical effects of growth hormone treatment in children with Prader–Willi syndrome
J2  - Acta Paediatr
PY  - 1999
VL  - 88
IS  - Suppl.
SP  - 112
EP  - 114
ER  - 
TY  - JOUR
LB  - 97.
AU  - Myers, SE
AU  - Whitman, BY
AU  - Carrel, AL
AU  - Moerchen, V
AU  - Bekx, MT
AU  - Allen, DB
TI  - Two years of growth hormone therapy in young children with Prader–Willi syndrome: Physical and neurodevelopmental benefits
J2  - Am J Med Genet
PY  - 2007
VL  - 143A
SP  - 443
EP  - 448
ER  - 
TY  - JOUR
LB  - 98.
AU  - Whitman, B
AU  - Carrel, A
AU  - Bekx, T
AU  - Weber, C
AU  - Allen, D
AU  - Myers, S
TI  - Growth hormone improves body composition and motor development in infants with Prader–Willi syndrome after six months
J2  - J Pediatr Endocrinol
PY  - 2004
VL  - 17
SP  - 591
EP  - 600
ER  - 
TY  - JOUR
LB  - 99.
AU  - Hauffa, BP
TI  - One-year results of growth hormone treatment of short stature in Prader–Willi syndrome
J2  - Acta Paediatr
PY  - 1997
VL  - 423
IS  - Suppl.
SP  - 63
EP  - 65
ER  - 
TY  - JOUR
LB  - 100.
AU  - Lindgren, AC
AU  - Hagenas, L
AU  - Muller, J
AU  - Blichfeldt, S
AU  - Rosenborg, M
AU  - Brismar, T
TI  - Effects of growth hormone treatment on growth and body composition in Prader–Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group
J2  - Acta Paediatr
PY  - 1997
VL  - 423
IS  - Suppl.
SP  - 60
EP  - 62
ER  - 
TY  - JOUR
LB  - 101.
AU  - Lindgren, AC
AU  - Hagenas, L
AU  - Muller, J
AU  - Blichfeldt, S
AU  - Rosenborg, M
AU  - Brismar, T
TI  - Growth hormone treatment of children with Prader–Willi syndrome affects linear growth and body composition favourably
J2  - Acta Paediatr
PY  - 1998
VL  - 87
SP  - 28
EP  - 31
ER  - 
TY  - JOUR
LB  - 102.
AU  - Haqq, AM
AU  - Stadler, DD
AU  - Jackson, RH
AU  - Rosenfeld, RG
AU  - Purnell, JQ
AU  - LaFranchi, SH
TI  - Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader–Willi syndrome
J2  - J Clin Endocrinol Metab
PY  - 2003
VL  - 88
SP  - 2206
EP  - 2212
ER  - 
TY  - JOUR
LB  - 103.
AU  - Sanchez, CP
AU  - Kuizon, BD
AU  - Goodman, WG
AU  - Gales, B
AU  - Ettenger, RB
AU  - Boechat, MI
TI  - Growth hormone and the skeleton in pediatric renal allograft recipients
J2  - Pediatr Nephrol
PY  - 2002
VL  - 17
SP  - 322
EP  - 328
ER  - 
TY  - JOUR
LB  - 104.
AU  - Hokken-Koelega, ACS
AU  - Stijnen, T
AU  - De Muinck Keizer-Schrama, SMPF
AU  - Wit, JM
AU  - Wolff, ED
AU  - De Jong, MCJW
TI  - Placebo-controlled, double-blind, crossover trial of growth hormone treatment in prepubertal children with chronic renal failure
J2  - Lancet
PY  - 1991
VL  - 338
SP  - 585
EP  - 590
ER  - 
TY  - JOUR
LB  - 105.
AU  - Hokken-Koelega, AC
AU  - Stijnen, T
AU  - de Jong, RC
AU  - Donckerwolcke, RA
AU  - Groothoff, JW
AU  - Wolff, ED
TI  - A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant
J2  - Kidney Int
PY  - 1996
VL  - 53
IS  - Suppl.
SP  - 128
EP  - 134
ER  - 
TY  - JOUR
LB  - 106.
AU  - Powell, DR
AU  - Liu, F
AU  - Baker, BK
AU  - Hintz, RL
AU  - Lee, PD
AU  - Durham, SK
TI  - Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group
J2  - Kidney Int
PY  - 1997
VL  - 51
SP  - 1970
EP  - 1979
ER  - 
TY  - JOUR
LB  - 107.
AU  - Broyer, M
AU  - Jureidini, KF
AU  - Proesmans, W
AU  - Janssen, F
AU  - van Acker, K
AU  - Du Caju, M
TI  - Pharmacia & Upjohn Study Group. Results and side-effects of treating children with growth hormone after kidney transplantation – a preliminary report
J2  - Acta Paediatrica
PY  - 1996
VL  - 417
IS  - Suppl.
SP  - 76
EP  - 79
ER  - 
TY  - JOUR
LB  - 108.
AU  - Fine, RN
AU  - Kohaut, MEC
AU  - Brown, MD
AU  - Perlman, AJ
TI  - Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study
J2  - J Pediatr
PY  - 1994
VL  - 124
SP  - 374
EP  - 382
ER  - 
TY  - JOUR
LB  - 109.
AU  - De Schepper, J
AU  - Thomas, M
AU  - Beckers, D
AU  - Craen, M
AU  - Maes, M
AU  - de Zegher, F
TI  - Growth hormone treatment and fat redistribution in children born small for gestational age
J2  - J Pediatr
PY  - 2008
VL  - 152
SP  - 327
EP  - 330
ER  - 
TY  - JOUR
LB  - 110.
AU  - Lagrou, K
AU  - Froidecoeur, C
AU  - Thomas, M
AU  - Massa, G
AU  - Beckers, D
AU  - Craen, M
TI  - Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age
J2  - Horm Res
PY  - 2008
VL  - 69
SP  - 334
EP  - 342
ER  - 
TY  - JOUR
LB  - 111.
AU  - Carel, JC
AU  - Chatelain, P
AU  - Rochiccioli, P
AU  - Chaussain, JL
TI  - Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study
J2  - J Clin Endocrinol Metab
PY  - 2003
VL  - 88
SP  - 1587
EP  - 1593
ER  - 
TY  - JOUR
LB  - 112.
AU  - de Zegher, F
AU  - Maes, M
AU  - Gargosky, SE
AU  - Heinrichs, C
AU  - Du Caju, MVL
AU  - Thiry, G
TI  - High-dose growth hormone treatment of short children born small for gestational age
J2  - J Clin Endocrinol Metab
PY  - 1996
VL  - 81
SP  - 1887
EP  - 1892
ER  - 
TY  - JOUR
LB  - 113.
AU  - de Zegher, F
AU  - Ong, K
AU  - van, HM
AU  - Mohn, A
AU  - Woods, K
AU  - Dunger, D
TI  - High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity
J2  - J Clin Endocrinol Metab
PY  - 2002
VL  - 87
SP  - 148
EP  - 151
ER  - 
TY  - JOUR
LB  - 114.
AU  - Phillip, M
AU  - Lebenthal, Y
AU  - Lebl, J
AU  - Zuckerman-Levin, N
AU  - Korpal-Szczyrska, M
AU  - Marques, JS
TI  - European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens
J2  - Horm Res
PY  - 2009
VL  - 71
SP  - 52
EP  - 59
ER  - 
TY  - JOUR
LB  - 115.
AU  - Cutfield, W
AU  - Lindberg, A
AU  - Chatelain, P
AU  - Ranke, M
AU  - Wilton, P
TI  - Final height in idiopathic growth hormone deficiency: the KIGS experience
J2  - Acta Paediatr
PY  - 1999
VL  - 88
IS  - Suppl.
SP  - 72
EP  - 75
ER  - 
TY  - JOUR
LB  - 116.
AU  - August, G
AU  - Julius, J
AU  - Blethen, S
TI  - Adult height in children with growth hormone deficiency
J2  - Paediatrics
PY  - 1998
VL  - 102
SP  - 16
ER  - 
TY  - JOUR
LB  - 117.
AU  - Dacou-Voutetakis, C
AU  - Karavanaki-Karanassiou, K
AU  - Petrou, V
AU  - Georgopoulos, N
AU  - Maniati-Christidi, M
AU  - Mavrou, A
TI  - The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment
J2  - Paediatrics
PY  - 1998
VL  - 101
SP  - 663
EP  - 668
ER  - 
TY  - JOUR
LB  - 118.
AU  - Hochberg, Z
AU  - Zadik, Z
TI  - Final height in young women with Turner syndrome after GH therapy: an open controlled study
J2  - Eur J Endocrinol
PY  - 1999
VL  - 141
SP  - 218
EP  - 224
ER  - 
TY  - JOUR
LB  - 119.
AU  - Pasquino, AM
AU  - Passeri, F
AU  - Municchi, G
AU  - Segni, M
AU  - Pucarelli, I
AU  - Larizza, D
TI  - Final height in Turner syndrome patients treated with growth hormone
J2  - Horm Res
PY  - 1996
VL  - 46
SP  - 72
ER  - 
TY  - JOUR
LB  - 120.
AU  - Taback, SP
AU  - Collu, R
AU  - Deal, CL
AU  - Guyda, HJ
AU  - Salisbury, S
AU  - Dean, HJ
TI  - Does growth-hormone supplementation affect adult height in Turner’s syndrome?
J2  - Lancet
PY  - 1996
VL  - 348
SP  - 25
EP  - 27
ER  - 
TY  - JOUR
LB  - 121.
AU  - Haffner, D
AU  - Schaefer, F
AU  - Nissel, R
AU  - Wuhl, E
AU  - Tonshoff, B
AU  - Mehls, O
TI  - Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure
J2  - N Engl J Med
PY  - 2000
VL  - 343
SP  - 923
EP  - 930
ER  - 
TY  - JOUR
LB  - 122.
AU  - Janssen, F
AU  - Van Damme, L
AU  - Van Dyck, M
AU  - Hall, M
AU  - Schurmans, T
AU  - Herman, J
TI  - Impact of growth hormone treatment on a Belgian population of short children with renal allografts
J2  - Pediatr Transplant
PY  - 1997
VL  - 1
SP  - 6
ER  - 
TY  - JOUR
LB  - 123.
AU  - Angulo, M
AU  - Castro-Magana, M
AU  - Canas, J
AU  - Arguello, R
AU  - Lamerson, M
AU  - Tapiador, C
TI  - Final height in Prader-Willi syndrome (PWS) children treated with recombinant growth hormone (rhGH)
J2  - Pediatr Res
PY  - 2000
VL  - 47
SP  - 1400
ER  - 
TY  - JOUR
LB  - 124.
AU  - Rosenfeld, RG
TI  - Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results
J2  - J Endocrinol Invest
PY  - 1989
VL  - 12
SP  - 49
EP  - 51
ER  - 
TY  - JOUR
LB  - 125.
AU  - Rosenfeld, RG
TI  - Non-conventional growth hormone therapy in Turner syndrome: the United States experience
J2  - Horm Res
PY  - 1990
VL  - 33
SP  - 137
EP  - 143
ER  - 
TY  - JOUR
LB  - 126.
AU  - Ross, JL
AU  - Feuillan, P
AU  - Kushner, H
AU  - Roeltgen, D
AU  - Cutler, GB, Jr.
TI  - Absence of growth hormone effects on cognitive function in girls with Turner syndrome
J2  - J Clin Endocrinol Metab
PY  - 1997
VL  - 82
SP  - 1814
EP  - 1817
ER  - 
TY  - JOUR
LB  - 127.
AU  - Whitman, BY
AU  - Myers, S
AU  - Carrel, A
AU  - Allen, DA
TI  - treatment/control group study of growth hormone treatment: Impact on behavior – A preliminary look
J2  - Endocrinologist
PY  - 2000
VL  - 10
IS  - Suppl.
SP  - 31
EP  - 37
ER  - 
TY  - JOUR
LB  - 128.
AU  - Conway, GS
AU  - Szarras-Czapnik, M
AU  - Racz, K
AU  - Keller, A
AU  - Chanson, P
AU  - Tauber, M
TI  - Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency
J2  - Eur J Endocrinol
PY  - 2009
VL  - 160
SP  - 899
EP  - 907
ER  - 
TY  - JOUR
LB  - 129.
AU  - Mauras, N
AU  - Pescovitz, OH
AU  - Allada, V
AU  - Messig, M
AU  - Wajnrajch, MP
AU  - Lippe, B
TI  - Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial
J2  - J Clin Endocrinol Metab
PY  - 2005
VL  - 90
SP  - 3946
EP  - 3955
ER  - 
TY  - JOUR
LB  - 130.
AU  - Attanasio, AF
AU  - Shavrikova, E
AU  - Blum, WF
AU  - Cromer, M
AU  - Child, CJ
AU  - Paskova, M
TI  - Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients
J2  - J Clin Endocrinol Metab
PY  - 2004
VL  - 89
SP  - 4857
EP  - 4862
ER  - 
TY  - JOUR
LB  - 131.
AU  - Norrelund, H
AU  - Vahl, N
AU  - Juul, A
AU  - Moller, N
AU  - Alberti, KG
AU  - Skakkebaek, NE
TI  - Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism
J2  - J Clin Endocrinol Metab
PY  - 2000
VL  - 85
SP  - 1912
EP  - 1917
ER  - 
TY  - JOUR
LB  - 132.
AU  - Underwood, LE
AU  - Attie, KM
AU  - Baptista, J
AU  - Genentech Collaborative Study Group
TI  - Growth hormone (GH) dose–response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study
J2  - J Clin Endocrinol Metab
PY  - 2003
VL  - 88
SP  - 5273
EP  - 5280
ER  - 
TY  - JOUR
LB  - 133.
AU  - Drake, WM
AU  - Carroll, PV
AU  - Maher, KT
AU  - Metcalfe, KA
AU  - Camacho-Hubner, C
AU  - Shaw, NJ
TI  - The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth
J2  - J Clin Endocrinol Metab
PY  - 2003
VL  - 88
SP  - 1658
EP  - 1663
ER  - 
TY  - JOUR
LB  - 134.
AU  - Baxter, L
AU  - Bryant, J
AU  - Cave, CB
AU  - Milne, R
TI  - Recombinant growth hormone for children and adolescents with Turner syndrome
J2  - Cochrane Database Syst Rev
PY  - 2007
VL  - 1
ER  - 
TY  - BOOK
LB  - 135.
AU  - Li, H
AU  - Banerjee, S
AU  - Dunfield, L
AU  - Kirby, J
AU  - Jones, M
AU  - Hamilton, J
TI  - Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
PB  - Canadian Agency for Drugs and Technologies in Health (CADTH)
PY  - 2007
ER  - 
TY  - JOUR
LB  - 136.
AU  - Drummond, MF
AU  - Jefferson, TO
TI  - Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party
J2  - BMJ
PY  - 1996
VL  - 313
SP  - 275
EP  - 283
ER  - 
TY  - JOUR
LB  - 137.
AU  - Weinstein, MC
AU  - O’Brien, B
AU  - Hornberger, J
AU  - Jackson, J
AU  - Johannesson, M
AU  - McCabe, C
TI  - Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices: Modeling Studies
J2  - Value Health
PY  - 2003
VL  - 6
SP  - 9
EP  - 17
ER  - 
TY  - GEN
LB  - 138.
AU  - National Institute for Health and Clinical Excellence
TI  - Guide to the methods of technology appraisal
CY  - London
PB  - NICE
PY  - 2008
ER  - 
TY  - JOUR
LB  - 139.
AU  - Joshi, AV
AU  - Munro, V
AU  - Russell, MW
TI  - Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children
J2  - Curr Med Res Opin
PY  - 2006
VL  - 22
SP  - 351
EP  - 357
ER  - 
TY  - GEN
LB  - 140.
AU  - Anthony, D
AU  - Stevens, A
TI  - Growth hormone in children (for growth hormone deficiency, Turner’s syndrome, chronic renal failure and idiopathic short stature)
PY  - 1996
ER  - 
TY  - BOOK
LB  - 141.
AU  - Drummond, MF
AU  - O’Brien, B
AU  - Stoddart, GL
AU  - Torrance, GW
TI  - Methods for the economic evaluation of health care programmes
ET  - 3rd
CY  - Oxford
PB  - Oxford University Press
PY  - 2005
ER  - 
TY  - JOUR
LB  - 142.
AU  - Wit, J-M
AU  - Boersma, B
AU  - De Muinck Keizer-Schrama, SMPF
AU  - Nienhuis, HE
AU  - Oostdijk, W
AU  - Otten, BJ
TI  - Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues
J2  - Clin Endocrinol
PY  - 1995
VL  - 42
SP  - 365
EP  - 372
ER  - 
TY  - JOUR
LB  - 143.
AU  - Bannink, EM
AU  - Raat, H
AU  - Mulder, PG
AU  - Keizer-Schrama, SM
TI  - Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome
J2  - J Pediatr
PY  - 2006
VL  - 148
SP  - 95
EP  - 101
ER  - 
TY  - JOUR
LB  - 144.
AU  - Bertella, L
AU  - Mori, I
AU  - Grugni, G
AU  - Pignatti, R
AU  - Ceriani, F
AU  - Molinari, E
TI  - Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study
J2  - J Intellect Disabil Res
PY  - 2007
VL  - 51
SP  - 302
EP  - 311
ER  - 
TY  - JOUR
LB  - 145.
AU  - Busschbach, JJ
AU  - Rikken, B
AU  - Grobbee, DE
AU  - De Charro, FT
AU  - Wit, JM
TI  - Quality of life in short adults
J2  - Horm Res
PY  - 1998
VL  - 49
SP  - 32
EP  - 38
ER  - 
TY  - JOUR
LB  - 146.
AU  - Carel, JC
AU  - Ecosse, E
AU  - Bastie-Sigeac, I
AU  - Cabrol, S
AU  - Tauber, M
AU  - Leger, J
TI  - Quality of life determinants in young women with turner’s syndrome after growth hormone treatment: results of the StaTur population-based cohort study
J2  - J Clin Endocrinol Metab
PY  - 2005
VL  - 90
SP  - 1992
EP  - 1997
ER  - 
TY  - JOUR
LB  - 147.
AU  - Koltowska-Haggstrom, MK
TI  - Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: A precursor to cost-utility analysis
J2  - Clin Endocrinol
PY  - 2008
VL  - 68
SP  - 122
EP  - 129
ER  - 
TY  - JOUR
LB  - 148.
AU  - Sandberg, DE
AU  - MacGillivray, MH
AU  - Clopper, RR
AU  - Fung, C
AU  - LeRoux, L
AU  - Alliger, DE
TI  - Quality of life among formerly treated childhood-onset growth hormone-deficient adults: a comparison with unaffected siblings
J2  - J Clin Endocrinol Metab
PY  - 1998
VL  - 83
SP  - 1134
EP  - 1142
ER  - 
TY  - JOUR
LB  - 149.
AU  - Ara, R
AU  - Brazier, J
TI  - Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)
J2  - Value Health
PY  - 2008
ER  - 
TY  - JOUR
LB  - 150.
AU  - Christensen, TL
AU  - Djurhuus, CB
AU  - Clayton, P
AU  - Christiansen, JS
TI  - An evaluation of the relationship between adult height and health-related quality of life in the general UK population
J2  - Clin Endocrinol
PY  - 2007
VL  - 67
SP  - 407
EP  - 412
ER  - 
TY  - BOOK
LB  - 151.
AU  - Sproston, K
AU  - Primatesta, P
TI  - Health Survey for England 2003. Volume 1: Cardiovascular disease
CY  - London
PB  - HMSO
PY  - 2004
ER  - 
TY  - JOUR
LB  - 152.
AU  - Petrou, S
AU  - McIntosh, E
TI  - Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
J2  - Arch Dis Child
PY  - 2008
VL  - 93
SP  - 95
EP  - 97
ER  - 
TY  - GEN
LB  - 153.
AU  - Pfizer UK
TI  - KIGS (Pfizer International growth study) database for Western Europe
TI  - The clinical and cost-effectiveness of growth hormone (Genotropin®) in children
PB  - Pfizer submission to NICE
PY  - 2008
ER  - 
TY  - JOUR
LB  - 154.
AU  - Fryback, DG
AU  - Lawrence, WF
AU  - Martin, PA
AU  - Klein, R
AU  - Klein, BE
TI  - Predicting Quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study
J2  - Med Decis Making
PY  - 1997
VL  - 17
SP  - 1
EP  - 9
ER  - 
TY  - JOUR
LB  - 155.
AU  - Shmueli, A
TI  - The SF-36 profile and health-related quality of life: an interpretative analysis
J2  - Qual Life Res
PY  - 1998
VL  - 7
SP  - 187
EP  - 195
ER  - 
TY  - JOUR
LB  - 156.
AU  - Cooper, K
AU  - Brailsford, SC
AU  - Davies, R
AU  - Raftery, J
TI  - Modelling health care interventions
J2  - J Oper Res Soc
PY  - 2007
VL  - 58
SP  - 168
EP  - 176
ER  - 
TY  - JOUR
LB  - 157.
AU  - Kapoor, RR
AU  - Burke, SA
AU  - Sparrow, SE
AU  - Hughes, IA
AU  - Dunger, DB
AU  - Ong, KK
TI  - Monitoring of concordance in growth hormone therapy
J2  - Arch Dis Child
PY  - 2008
VL  - 93
SP  - 147
EP  - 148
ER  - 
TY  - JOUR
LB  - 158.
AU  - Bonfig, W
AU  - Bechtold, S
AU  - Bachmann, S
AU  - Putzker, S
AU  - Fuchs, O
AU  - Pagel, P
TI  - Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood
J2  - J Pediatr Endocrinol Metab
PY  - 2008
VL  - 21
SP  - 1049
EP  - 1056
ER  - 
TY  - BOOK
LB  - 159.
AU  - Briggs, A
AU  - Sculpher, M
AU  - Claxton, K
TI  - Decision modelling for health economic evaluation
CY  - Oxford
PB  - Oxford University Press
PY  - 2006
ER  - 
TY  - JOUR
LB  - 160.
AU  - Nielsen, EH
AU  - Lindholm, J
AU  - Laurberg, P
TI  - Excess mortality in women with pituitary disease: a meta-analysis
J2  - Clin Endocrinol
PY  - 2007
VL  - 67
SP  - 693
EP  - 697
ER  - 
TY  - JOUR
LB  - 161.
AU  - Shoemaker, MJ
AU  - Swerdlow, AJ
AU  - Higgins, CD
AU  - Wright, AF
AU  - Jacobs, PA
TI  - Mortality in women with turner syndrome in Great Britain: a national cohort study
J2  - J Clin Endocrinol Metab
PY  - 2008
VL  - 93
SP  - 4735
EP  - 4742
ER  - 
TY  - JOUR
LB  - 162.
AU  - Lee, PDK
TI  - Growth hormone and mortality in Prader–Willi syndrome
J2  - Growth Genetics & Hormones
PY  - 2006
VL  - 22
SP  - 17
EP  - 23
ER  - 
TY  - JOUR
LB  - 163.
AU  - Groothoff, JW
TI  - Long-term outcomes of children with end-stage renal disease
J2  - Pediatr Nephrol
PY  - 2005
VL  - 20
SP  - 849
EP  - 853
ER  - 
TY  - JOUR
LB  - 164.
AU  - Kajantie, E
AU  - Osmond, C
AU  - Barker, DJ
AU  - Forsen, T
AU  - Phillips, DI
AU  - Eriksson, JG
TI  - Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years
J2  - Int J Epidemiol
PY  - 2005
VL  - 34
SP  - 655
EP  - 663
ER  - 
TY  - GEN
LB  - 165.
AU  - British Medical Association and Royal Pharmaceutical Society of Great Britain
TI  - British national formulary
CY  - London
PB  - BMA and RPS
PY  - 2009
ER  - 
TY  - GEN
LB  - 166.
AU  - Department of Health
TI  - NHS reference costs
CY  - London
PB  - DoH
PY  - 2006
ER  - 
TY  - BOOK
LB  - 167.
AU  - Curtis, L
TI  - Unit costs of health and social care
CY  - University of Kent, Canterbury
PB  - Personal Social Services Research Unit
PY  - 2008
ER  - 
TY  - JOUR
LB  - 168.
AU  - Picot, J
AU  - Jones, J
AU  - Colquitt, J
AU  - Gospodaresvskaya, E
AU  - Loveman, E
AU  - Baxter, L
TI  - The clinical-effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
J2  - Health Technol Assess
PY  - 2009
VL  - 13
IS  - 41
ER  - 
TY  - JOUR
LB  - 169.
AU  - Hakim, Z
AU  - Wolf, A
AU  - Garrison, L.P
TI  - Estimating the effect of changes in body mass index on health state preferences
J2  - Pharmacoeconomics
PY  - 2008
VL  - 20
SP  - 393
EP  - 404
ER  - 
TY  - JOUR
LB  - 170.
AU  - Bengtsson, BA
TI  - Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism
J2  - Growth Horm IGF Res
PY  - 1998
VL  - 8
IS  - Suppl.
SP  - 77
EP  - 80
ER  - 
TY  - JOUR
LB  - 171.
AU  - Evers, S
AU  - Goossens, M
AU  - de Vet, H
AU  - van Tulder, M
AU  - Ament, A
TI  - Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria
J2  - Int J Technol Assess Health Care
PY  - 2005
VL  - 21
SP  - 240
EP  - 245
ER  - 
TY  - JOUR
LB  - 172.
AU  - Philips, Z
AU  - Ginnelly, L
AU  - Sculpher, M
AU  - Claxton, K
AU  - Golder, S
AU  - Riemsma, R
TI  - Review of guidelines for good practice in decision-analytic modelling in health technology assessment
J2  - Health Technol Assess
PY  - 2004
VL  - 8
SP  - 36
ER  -